Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Swaddling and Breast Milk Odor for Stress and Comfort in Late Preterm Babies Receiving High-Flow Breathing Support Through the Nose

10 de noviembre de 2026 actualizado por: Hediye Karakoç, KTO Karatay University

The Effect of the Safe Swaddling Method and the Scent of Breast Milk on Physiological Parameters, Stress, and Comfort Levels in Premature Newborns Receiving Mechanical Ventilator Support: A Randomized Controlled Study

This study compared two approaches to reducing stress and improving comfort in babies born between 34 and 36 completed weeks of pregnancy who were receiving high-flow breathing support through small tubes in the nose.

Seventy-two babies were assigned by chance to one of three groups, with 24 babies in each group. One group was gently swaddled for 20 minutes. A second group was exposed for 20 minutes to the smell of freshly expressed milk from each baby's own mother. The third group received the neonatal intensive care unit's usual care and was observed for 20 minutes.

The study team assessed stress and comfort and recorded heart rate, breathing rate, blood oxygen level, and body temperature at the start of the observation period and again at 5 and 20 minutes. The purpose was to compare how these measures changed over time across the three groups.

Descripción general del estudio

Estado

Terminado

Condiciones

Tipo de estudio

Intervencionista

Inscripción (Actual)

72

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Karatay
      • Konya, Karatay, Turquía (Türkiye), 42040
        • KTO Karatay University

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

7 meses a 8 meses (Niño)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Gestational age at birth of 34 weeks 0 days to 36 weeks 6 days, inclusive.
  • Within the first 28 days of life at enrollment.
  • Receiving noninvasive respiratory support via a high-flow nasal cannula (HFNC).
  • Birth weight of at least 1,500 g.
  • The infant's mother was able to provide expressed breast milk.
  • No clinical condition that precluded safe positioning or swaddling.
  • Written informed consent obtained from a parent.

Exclusion Criteria:

  • A painful procedure within 1 hour before the start of the planned study session.
  • Receipt of a medication with analgesic or sedative effects within 6 hours before the start of the planned study session.
  • Previous surgery.
  • An active or treatment-requiring clinical condition that could affect physiological measurements or the stress response, such as hypoglycemia, hyperbilirubinemia, or acute infection.
  • Cerebral hypoxia or ischemia.
  • Intraventricular hemorrhage.
  • A major congenital anomaly.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Maternal Breast Milk Odor

Infants were exposed for 20 minutes to the odor of freshly expressed breast milk from their own mothers. Ten drops of milk were applied to sterile gauze placed in a sterile container. The container was positioned inside the incubator approximately 1-2 cm from the infant's nose and remained in place throughout the exposure period.

Ten drops of freshly expressed breast milk from each infant's own mother were applied to sterile gauze in a sterile container. The container was placed inside the incubator near the infant's nose for 20 minutes.

Experimental: Safe Swaddling

Infants were positioned supine and swaddled for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The upper limbs were held alongside the trunk in slight flexion. The lower limbs were left free to allow hip flexion and abduction. The cloth was secured loosely enough to permit chest expansion and spontaneous movement.

Infants were swaddled in the supine position for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The cloth was secured loosely to allow chest expansion and spontaneous movement, and the lower limbs were left free to permit hip flexion and abduction.

Sin intervención: Standard Care

Infants received the neonatal intensive care unit's standard care during a 20-minute observation period. No additional study intervention was administered.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Newborn Stress Scale Total Score Over Time
Periodo de tiempo: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Stress was assessed using the Newborn Stress Scale. The scale comprises eight observational domains, each scored from 0 to 2. Total scores range from 0 to 16, with higher scores indicating greater stress. Changes in total scores across the three assessment time points were compared among the study groups.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Premature Infant Comfort Scale Total Score
Periodo de tiempo: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Comfort was assessed using the Turkish version of the Premature Infant Comfort Scale. Seven indicators are each scored from 1 to 5. Total scores range from 7 to 35, with lower scores indicating greater comfort.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Heart Rate
Periodo de tiempo: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Heart rate was read directly from the bedside monitor and recorded in beats per minute.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Respiratory Rate
Periodo de tiempo: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Respiratory rate was read directly from the bedside monitor and recorded in breaths per minute.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Peripheral Oxygen Saturation (SpO₂)
Periodo de tiempo: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Peripheral oxygen saturation was read directly from the bedside monitor and recorded as a percentage.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Body Temperature
Periodo de tiempo: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Body temperature was read directly from the bedside monitor and recorded in degrees Celsius (°C).

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Hediye Karakoç, KTO Karatay Üniversitesi

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

28 de junio de 2024

Finalización primaria (Actual)

30 de abril de 2026

Finalización del estudio (Actual)

30 de agosto de 2026

Fechas de registro del estudio

Enviado por primera vez

19 de agosto de 2025

Primero enviado que cumplió con los criterios de control de calidad

1 de julio de 2026

Publicado por primera vez (Actual)

2 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

13 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

10 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Security

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir